Rigel Pharmaceuticals, Inc. (RIGL)
32.18
+2.81
(+9.57%)
USD |
NASDAQ |
May 13, 16:00
32.77
+0.59
(+1.83%)
After-Hours: 20:00
Rigel Pharmaceuticals Free Cash Flow : 79.27M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Madrigal Pharmaceuticals, Inc. | -275.41M |
| Xencor, Inc. | -188.84M |
| CytomX Therapeutics, Inc. | -80.19M |
| AnaptysBio, Inc. | 19.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.725M |
| Cash from Investing (Quarterly) | -7.975M |
| Cash from Financing (Quarterly) | -10.92M |
| Free Cash Flow Per Share (Quarterly) | 0.1384 |
| Free Cash Flow to Equity (Quarterly) | 10.31M |
| Free Cash Flow to Firm (Quarterly) | 3.789M |
| Free Cash Flow Yield | 12.83% |